Riverside Pharmacueticals Corporation
1 clinical trials · Sponsor
◉ Watch Riverside Pharmacueticals Corporation
| Record | Firm | Date |
|---|---|---|
| Bioequivalence Bewteen DopaSnap® (Cabidopa/Levopdoap 25/100 mg Tablet) and Carbidopa/Levodopa 25/100 mg Tablet (Actavis) (NCT04236921) | Riverside Pharmacueticals Corporation | 2019-07-15 |
Track Riverside Pharmacueticals Corporation automatically
Every clearance here is in the API, with alerts when new ones post.